A systematic review of worldwide incidence of nonmelanoma skin cancer.
TLDR
This poster presents a probabilistic procedure that can be used to select patients suitable for surgery for nonmelanoma skin cancer (NMSC) with a high likelihood of survival.Abstract:
Background Nonmelanoma skin cancer (NMSC) is the most common cancer affecting white-skinned individuals and the incidence is increasing worldwide. Objectives This systematic review brings together 75 studies conducted over the past half century to look at geographical variations and trends worldwide in NMSC, and specifically incidence data are compared with recent U.K. cancer registry data. Methods Following the development of a comprehensive search strategy, an assessment tool was adapted to look at the methodological quality of the eligible studies. Results Most of the studies focused on white populations in Europe, the U.S.A. and Australia; however, limited data were available for other skin types in regions such as Africa. Worldwide the incidence for NMSC varies widely with the highest rates in Australia [>1000/100, 000 person-years for basal cell carcinoma (BCC)] and the lowest rates in parts of Africa ( Conclusions NMSC is an increasing problem for health care services worldwide. This review highlights a requirement for prevention studies in this area and the issues surrounding incomplete NMSC registration. Registration standards of NMSC should be improved to the level of other invasive disease.read more
Citations
More filters
Journal ArticleDOI
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016: A Systematic Analysis for the Global Burden of Disease Study.
Christina Fitzmaurice,Christina Fitzmaurice,Christina Fitzmaurice,Tomi Akinyemiju,Faris Lami,Tahiya Alam,Reza Alizadeh-Navaei,Christine Allen,Ubai Alsharif,Nelson Alvis-Guzman,Erfan Amini,Benjamin O. Anderson,Olatunde Aremu,Al Artaman,Solomon Weldegebreal Asgedom,Reza Assadi,Tesfay Mehari Atey,Leticia Avila-Burgos,Ashish Awasthi,Huda Omer Ba Saleem,Aleksandra Barac,James R. Bennett,Isabela M. Benseñor,Nickhill Bhakta,Hermann Brenner,Lucero Cahuana-Hurtado,Carlos A Castañeda-Orjuela,Ferrán Catalá-López,Ferrán Catalá-López,Jee-Young Jasmine Choi,Jee-Young Jasmine Choi,Devasahayam J. Christopher,Sheng-Chia Chung,Maria Paula Curado,Lalit Dandona,Lalit Dandona,Rakhi Dandona,Rakhi Dandona,José Neves,Subhojit Dey,Samath D Dharmaratne,David Teye Doku,David Teye Doku,Tim Driscoll,Manisha Dubey,Hedyeh Ebrahimi,Dumessa Edessa,Ziad El-Khatib,Ziad El-Khatib,Aman Yesuf Endries,Florian Fischer,Lisa M. Force,Kyle J Foreman,Kyle J Foreman,Solomon Weldemariam Gebrehiwot,Sameer Vali Gopalani,Giuseppe Grosso,Rahul Gupta,Bishal Gyawali,Randah R. Hamadeh,Samer Hamidi,James D. Harvey,Hamid Yimam Hassen,Roderick J. Hay,Simon I. Hay,Simon I. Hay,Behzad Heibati,Molla Kahssay Hiluf,Nobuyuki Horita,H. Dean Hosgood,Olayinka Stephen Ilesanmi,Kaire Innos,Farhad Islami,Mihajlo Jakovljevic,Mihajlo Jakovljevic,Sarah Charlotte Johnson,Jost B. Jonas,Amir Kasaeian,Tesfaye Dessale Kassa,Yousef Khader,Ejaz Ahmad Khan,Gulfaraz Khan,Young-Ho Khang,Young-Ho Khang,Mohammad Hossein Khosravi,Mohammad Hossein Khosravi,Jagdish Khubchandani,Jacek A. Kopec,G Anil Kumar,Michael Kutz,Deepesh Lad,Alessandra Lafranconi,Qing Lan,Yirga Legesse,James Leigh,Shai Linn,Raimundas Lunevicius,Raimundas Lunevicius,Azeem Majeed,Reza Malekzadeh,Deborah Carvalho Malta,Lorenzo G. Mantovani,Brian J. McMahon,Toni Meier,Yohannes Adama Melaku,Yohannes Adama Melaku,Mulugeta Melku,Peter Memiah,Walter Mendoza,Tuomo J. Meretoja,Haftay Berhane Mezgebe,Ted R. Miller,Ted R. Miller,Shafiu Mohammed,Shafiu Mohammed,Ali H. Mokdad,Mahmood Moosazadeh,Paula Moraga,Seyyed Meysam Mousavi,Vinay Nangia,Cuong Tat Nguyen,Vuong Minh Nong,Felix Akpojene Ogbo,Andrew T Olagunju,Andrew T Olagunju,Andrew T Olagunju,Padukudru Anand Mahesh,Eun-Kee Park,Tejas Patel,David M. Pereira,Farhad Pishgar,Maarten J. Postma,Maarten J. Postma,Farshad Pourmalek,Mostafa Qorbani,Anwar Rafay,Salman Rawaf,David Laith Rawaf,David Laith Rawaf,Gholamreza Roshandel,Gholamreza Roshandel,Saeid Safiri,Hamideh Salimzadeh,Juan Sanabria,Juan Sanabria,Milena M Santric Milicevic,Benn Sartorius,Benn Sartorius,Maheswar Satpathy,Sadaf G. Sepanlou,Katya Anne Shackelford,Masood Ali Shaikh,Mahdi Sharif-Alhoseini,Jun She,Min-Jeong Shin,Ivy Shiue,Ivy Shiue,Mark G. Shrime,Abiy Hiruye Sinke,Mekonnen Sisay,Amber Sligar,Mu'awiyyah Babale Sufiyan,Bryan L. Sykes,Rafael Tabarés-Seisdedos,Gizachew Assefa Tessema,Gizachew Assefa Tessema,Roman Topor-Madry,Roman Topor-Madry,Tung Thanh Tran,Bach Xuan Tran,Bach Xuan Tran,Kingsley N. Ukwaja,Vasiliy Victorovich Vlassov,Stein Emil Vollset,Elisabete Weiderpass,Hywel C Williams,Nigus Bililign Yimer,Naohiro Yonemoto,Mustafa Z. Younis,Christopher J L Murray,Mohsen Naghavi +180 more
TL;DR: In this paper, the authors assess the burden of 29 cancer groups over time to provide a framework for policy discussion, resource allocation, and research focus, and evaluate cancer incidence, mortality, years lived with disability, years of life lost, and disability-adjusted life-years (DALYs) for 195 countries and territories by age and sex using the Global Burden of Disease study estimation methods.
Journal ArticleDOI
High burden and pervasive positive selection of somatic mutations in normal human skin
Inigo Martincorena,Amit Roshan,Moritz Gerstung,Peter R. Ellis,Peter Van Loo,Peter Van Loo,Peter Van Loo,Stuart McLaren,David C. Wedge,Anthony Fullam,Ludmil B. Alexandrov,Jose M. C. Tubio,Lucy Stebbings,Andrew Menzies,Sara Widaa,Michael R. Stratton,Philip H. Jones,Peter J. Campbell,Peter J. Campbell +18 more
TL;DR: Across 234 biopsies of sun-exposed eyelid epidermis from four individuals, the burden of somatic mutations averaged two to six mutations per megabase per cell, similar to that seen in many cancers, and exhibited characteristic signatures of exposure to ultraviolet light.
Journal ArticleDOI
PD-1 blockade with cemiplimab in advanced cutaneous squamous-cell carcinoma
Michael R. Migden,Danny Rischin,Chrysalyne D. Schmults,Alexander Guminski,Axel Hauschild,Karl D. Lewis,Christine H. Chung,Leonel Hernandez-Aya,Annette M. Lim,Anne Lynn S. Chang,Guilherme Rabinowits,Alesha A. Thai,Lara Dunn,Brett G.M. Hughes,Nikhil I. Khushalani,Badri Modi,Dirk Schadendorf,Bo Gao,Frank Seebach,Siyu Li,Jingjin Li,Melissa Mathias,Jocelyn Booth,Kosalai Kal Mohan,Elizabeth Stankevich,Hani M. Babiker,Irene Brana,Marta Gil-Martin,Jade Homsi,Melissa Lynne Johnson,Victor Moreno,Jiaxin Niu,Taofeek K. Owonikoko,Kyriakos P. Papadopoulos,George D. Yancopoulos,Israel Lowy,Matthew G. Fury +36 more
TL;DR: Among patients with advanced cutaneous squamous‐cell carcinoma, cemiplimab induced a response in approximately half the patients and was associated with adverse events that usually occur with immune checkpoint inhibitors.
Journal ArticleDOI
Prevalence and costs of skin cancer treatment in the U.S., 2002-2006 and 2007-2011.
TL;DR: Findings demonstrate that the health and economic burden of skin cancer treatment is substantial and increasing, and highlight the importance ofSkin cancer prevention efforts, which may result in future savings to the healthcare system.
Journal ArticleDOI
Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review
TL;DR: The incidence of idiopathic pulmonary fibrosis is increasing worldwide and rates are coming together across countries, and current data suggest incidence is similar to that of conditions such as stomach, liver, testicular and cervical cancers.
References
More filters
Journal ArticleDOI
From the authors
Y. Lacasse,F. Maltais +1 more
TL;DR: Findings, i.e. that as-needed AO provided for a period of 3 months had no effect on quality of life and walked distance, are against the stream of current guidelines.
Journal ArticleDOI
British Association of Dermatologists
TL;DR: The British Association of Dermatologists guidelines for biologic therapy for psoriasis 2017 included guidelines for transition to/between biologic therapies, as well as advice on how to identify and assess patients at risk of falling foul of these guidelines.
Journal ArticleDOI
The epidemiology of skin cancer.
Thomas L. Diepgen,V Mahler +1 more
TL;DR: Melanoma and non‐melanoma (basal and squamous cell carcinoma) skin cancer (NMSC) are now the most common types of cancer in the white populations and the incidence of skin cancer has reached epidemic proportions.
Journal ArticleDOI
The epidemiology of UV induced skin cancer.
Bruce K. Armstrong,Anne Kricker +1 more
TL;DR: The epidemiological data suggest that in implementing sun protection an increase in intermittency of exposure should be avoided, that sun protection will have the greatest impact if achieved as early as possible in life and that it will probably have an impact later in life, especially in those who had high childhood exposure to solar radiation.